The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Jul 2020 07:00

RNS Number : 0478S
Sabien Technology Group PLC
06 July 2020
 

6 July 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Trading Update

The Covid-19 pandemic has affected the entire global economy and Sabien has not escaped its impact. However, in spite of this unprecedented disruption, Sabien's revenues doubled in the second half of the financial year compared to the first half. This brings total sales (unaudited) for the year to approximately £460,000 (FY19: £1,379,000). The decrease in full year sales, while disappointing, is explained by last year's revenues including an exceptional order of £846,375 and by three months of lost sales due to the Covid lockdown in this period.

However, the Board believes that first half sales represent a "low watermark" after several years of diminishing performance by the previous Board and management team. Since the new management team has taken charge earlier this year, sales prospects are demonstrably strengthening, and consistent year-on-year growth is expected as the Company transitions into a more realisable go-to market strategy based on an enhanced product and service proposition.

In addition, the Board has sought to protect shareholder value in challenging market conditions by placing a focus on cash management. During the year cash in the bank has increased to £777,848 at 30 June 2020 (30 June 2019: £738,000; 30 June 2018: £9,000). This includes a Covid business interruption loan of £181,000 from NatWest Bank received on 25 June.

While Covid uncertainty has made it impossible to achieve a profitable performance this year, costs have been tightly controlled within the operating business as follows:

· Following, the announcement of major new strategic shareholder on 3 September 2019, the management team has been restructured with the departure of the Alan O'Brien, CEO, (announced 5/11/19) and David Bakst, Managing Director (announced (29/5/20). Until further notice these functions will filled by Executive Chairman, Richard Parris. These changes will contribute an annual saving on the operating company payroll of more than £200,000 from 1 June 2020.

· The Board placed 85% of the workforce on Covid-19 furlough from 31 March 2020. This has mitigated payroll expenses for 25% of the financial year and has helped to preserve jobs and expertise. During this period the Company was unable gain access to customer sites to undertake any installations but background sales and planning tasks to have been undertaken to the extent possible using non-furloughed staff.

The Company has recently started a development project to "cloud enable" its existing M2G user base (up to circa 10,500 units). This will enable upselling opportunities to existing customers and provide a source of new subscription revenue within the next period. For the first time in the Company's history this will enable recurring revenues to be generated from its large installed base. It is anticipated this will also reduce the time to secure new orders and support an international channel partner programme. Early revenues from this new Cloud service are expected before the end of 2020.

Operationally, Sabien is planning a strong start to the new financial period with a backlog of more than 300 M2G units to install and a confirmed order book of approximately £140,000. Commencing 16 June 2020, staff are being phased back from furlough leave to enable the Company to start to install backlogged units. The limiting factor is regaining access to customer sites which have been in lockdown since March. It is likely that full operations will restored within 3 months, with a new look business focused increasingly on indirect selling through channel partners in the UK and the US.

Richard Parris, Chairman, said: "The Sabien operating business is entering the new financial year in good shape to deliver year-on-year growth, relative to FY2020. This is a direct result of the Board's restructuring of the management and sales teams. During FY2021 and beyond we are expecting a sales bounce from (1) a post-Covid investment focus on green technology and (2) recessionary sentiments across the economy that will place a immediate customer emphasis on cost reduction programmes with short payback windows. I believe Sabien is now well placed to benefit from both of these macro trends and, in conjunction with our cost control measures, the Company is in a strong position for a return to profitability. The Board thanks Sabien staff for their support and forbearance during the difficult time of furlough and we look forward to welcoming you back over the coming weeks."

 

For further information:

Sabien Technology Group plc

Richard Parris, Chairman

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin / Matt Davis

Peterhouse Capital Limited (Broker)

Duncan Vasey/ Lucy Williams 

+44 20 7993 3700

 

+44 203 368 3550 

 

+44 207 469 0930

A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKNBQABKDNOK
Date   Source Headline
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker
15th Mar 20182:42 pmRNSDirector/PDMR Shareholding
28th Feb 20185:34 pmRNSDirector/PDMR Shareholding
28th Feb 20185:32 pmRNSDirector Loan
14th Feb 20182:59 pmRNSResult of General Meeting
5th Feb 20184:22 pmRNSDirector/PDMR Shareholding
31st Jan 201812:33 pmRNSUnaudited Interim Results to 31 December 2017
19th Jan 20185:10 pmRNSNotice of General Meeting
29th Dec 201711:21 amRNSResult of AGM
7th Dec 20173:10 pmRNSNotice of AGM
7th Dec 20177:00 amRNSAudited Annual Report
1st Aug 20177:00 amRNSChange of Adviser
30th Jun 20177:01 amRNSFinance Director Retirement
30th Jun 20177:00 amRNSOrder Received
20th Apr 20174:45 pmRNSHolding(s) in Company
20th Apr 20174:03 pmRNSHolding(s) in Company
20th Apr 201711:15 amRNSHolding(s) in Company
20th Apr 201711:13 amRNSHolding(s) in Company
20th Apr 201711:11 amRNSHolding(s) in Company
18th Apr 20174:56 pmRNSTotal Voting Rights
18th Apr 201711:51 amRNSResult of GM
29th Mar 201710:00 amRNSNotice of GM
29th Mar 20177:30 amRNSResults of Placing
29th Mar 20177:00 amRNSHalf-year Report
30th Dec 201610:05 amRNSHolding(s) in Company
29th Nov 201612:19 pmRNSResult of AGM
29th Nov 201610:41 amRNSAGM Statement
7th Nov 20165:28 pmRNSNotice of AGM
25th Oct 20167:00 amRNSFinal Results
29th Sep 20163:25 pmRNSHolding(s) in Company
22nd Sep 20164:56 pmRNSHolding(s) in Company
22nd Sep 20164:54 pmRNSHolding(s) in Company
22nd Sep 20164:48 pmRNSHolding(s) in Company
16th Sep 20167:00 amRNS£750,000 Placing To Continue Growth Strategy
13th Jul 201610:47 amRNSResult of Meeting
13th Jul 20169:08 amRNSGM Statement
27th Jun 20169:42 amRNSNotice of GM
2nd Jun 20167:00 amRNSTrading Statement
3rd May 20167:00 amRNSUpdate on pilot programme
9th Feb 20167:00 amRNSHalf Yearly Report
6th Jan 20169:44 amRNSChange of name of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.